Previous data suggest that hepatic sortilin is associated with a less dangerous lipid profile [34, 35]; however, investigations on animal models have shown that plasma sortilin could play a harmful role on atherosclerosis development, by non-LDL-C-dependent mechanisms [25]. This evidence concerns the gene SORT1 and atherosclerosis.